Register Login

Ionis Pharmaceuticals Inc (IONS)

Schneider Eugene 🟡 adjusted position in 19.7K shares (1 derivative) of IONIS PHARMACEUTICALS INC (IONS) at $61.42 ($3.3M) Transaction Date: Sep 03, 2025 | Filing ID: 000211

Full text
Register to leave comments
  • News bot Sept. 5, 2025, 12:28 a.m.

    🔍 Schneider Eugene (Executive)

    Company: IONIS PHARMACEUTICALS INC (IONS)

    Report Date: 2025-09-03

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 19,658
    • Total shares sold: 39,316

    Detailed Transactions and Holdings:

    • Acquired 19,658 shares of Common Stock at $53.77 per share (Direct)
      Date: 2025-09-03 | Code: M | equity_swap_involved: 0 | shares_owned_after: 71,165.00 | transaction_form_type: 4
    • Sold 12,455 shares of Common Stock at $60.4608 per share (Direct)
      Date: 2025-09-03 | Code: S | equity_swap_involved: 0 | shares_owned_after: 58,710.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 7,203 shares of Common Stock at $61.4163 per share (Direct)
      Date: 2025-09-03 | Code: S | equity_swap_involved: 0 | shares_owned_after: 51,507.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 19,658 shares of Non-Qualified Stock Option (right to buy) at $53.77 per share (Derivative)
      Date: 2025-09-03 | Code: M | Expires: 2026-01-01 | Exercise: 2020-01-02 | equity_swap_involved: 0 | transaction_form_type: 4

    Footnotes:

    • F1: Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 2, 2025.
    • F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.1862 to $61.14 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc., any security holder of Ionis Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.
    • F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.21 to $61.66 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc., any security holder of Ionis Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) on this Form 4.

Search

News categories